In type 2 DM, the HGF-Met system improves insulin sensitivity in mouse models of insulin resistance, likely through direct interactions between the Met receptor and the insulin receptor, affecting hepatic glucose management (Fafalios et al., 2011). This evidence concerns the gene HGF and Insulin resistance.